Stay updated on Depemokimab Clinical Trial in Severe Eosinophilic Asthma
Sign up to get notified when there's something new on the Depemokimab Clinical Trial in Severe Eosinophilic Asthma page.

Latest updates to the Depemokimab Clinical Trial in Severe Eosinophilic Asthma page
- Check6 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study criteria and descriptions related to GSK3511294 (Depemokimab) for asthma, while also updating the revision number from v2.14.4 to v2.15.0.SummaryDifference24%
- Check27 days agoChange DetectedThe page has updated its version from v2.14.3 to v2.14.4 and removed a date of March 25, 2025, while adding a new date of December 17, 2024.SummaryDifference0.5%
- Check34 days agoChange DetectedThe page has been updated to reflect a new version (v2.14.3) and a new date for the results first posted, now set for March 25, 2025. The previous estimated dates and version have been removed.SummaryDifference0.4%
- Check63 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
- Check85 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.8%
Stay in the know with updates to Depemokimab Clinical Trial in Severe Eosinophilic Asthma
Enter your email address, and we'll notify you when there's something new on the Depemokimab Clinical Trial in Severe Eosinophilic Asthma page.